CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Corticosteroids - topical (skin), nose, and eyes - How up-to-date is this topic?
Changes
Version 1.1, revision planned in 2014.
Last revised in August 2010
January 2011— Changed the title of the topic to corticosteroids - topical (skin), nose, and eyes. The initial title corticosteroids - topical (skin, nose, and eyes) was inappropriate because for the purpose for this topic, topical refers to corticosteroid preparations used on the skin. Also changed the term 'intraocular corticosteroids' to corticosteroid eye preparations through out the entire document, as it is a more accurate terminology.
September 2010 — minor update. The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded prescribers that psychological and behavioural side effects may occur in association with the use of intranasal corticosteroids [MHRA, 2010]. Issued in September 2010.
April to August 2010 — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.
© NHS Institute for Innovation and Improvement